Quarterly report pursuant to Section 13 or 15(d)

Accrued Expenses

v3.21.1
Accrued Expenses
3 Months Ended
Mar. 31, 2021
Payables And Accruals [Abstract]  
Accrued Expenses

8. Accrued Expenses

Accrued expenses consisted of the following as of March 31, 2021 and December 31, 2020 (in thousands):

 

 

 

March 31, 2021

 

 

December 31, 2020

 

External research and preclinical development

 

$

6,367

 

 

$

4,702

 

Employee compensation and benefits

 

 

2,180

 

 

 

5,715

 

Professional fees

 

 

503

 

 

 

602

 

Facilities and other

 

 

77

 

 

 

65

 

 

 

$

9,127

 

 

$

11,084